Log In
Print this Print this

CLS 1001, CLS-1001

  Manage Alerts
Collapse Summary General Information
Company Clearside Biomedical Inc.
DescriptionTriamcinolone acetonide delivered using the company's ocular microinjection platform
Molecular Target Glucocorticoid receptor (GCCR)
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today